跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
黃 于芳
教授
婦產學科
電子郵件
yufangh
mail.ncku.edu
tw
h-index
1343
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2004
2025
每年研究成果
概覽
指紋
網路
專案
(3)
研究成果
(38)
類似的個人檔案
(6)
指紋
查看啟用 Yu-Fang Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Drug Resistance
49%
Protein Kinase B
42%
Insulin-Like Growth Factor 1
26%
Cisplatin
25%
Phosphoinositide-Dependent Kinase-1
22%
Collagen, Type XI, Alpha 1
22%
Cell Invasion
20%
Transcription
20%
Carcinogenesis
19%
MicroRNA
17%
Downregulation
17%
MMP3
16%
Tumor Progression
15%
Promoter Region
14%
DNA Methyltransferase
13%
FOXM1
13%
Cell Fate
13%
Posttranslational Modification
13%
Ubiquitin
13%
Tretinoin
13%
Aldehyde Dehydrogenase
13%
Insulin-Like Growth Factor-Binding Protein
13%
IMP3
13%
Vitamin D
13%
Fibroblast
13%
Gelsolin
13%
Sodium-Hydrogen Antiporter
13%
Epidermal Growth Factor
13%
Insulin-Like Growth Factor 1 Receptor
11%
Progression Free Survival
9%
Overall Survival
9%
Ubiquitination
8%
Programmed Cell Death
8%
Cell Growth
7%
Mouse Model
6%
Binding Protein
5%
RNAI
5%
Messenger RNA
5%
Binding Site
5%
Chemosensitivity
5%
Medicine and Dentistry
Krukenberg Tumor
41%
Ovarian Cancer
30%
Gynecological Oncology
26%
Progression Free Survival
19%
Protein Binding
18%
Hazard Ratio
17%
Squamous Cell Carcinoma
16%
Neoplasm
15%
Cancer Cell
14%
Drug Resistance
14%
SUMO 3 Protein
13%
Cohort Analysis
13%
Plasmablastic Lymphoma
13%
Protein Kinase B Inhibitor
13%
Vitamin D Receptor
13%
Somatomedin C
13%
Oncology
13%
Uterine Cervix Carcinoma
13%
Peritoneum Cancer
13%
Somatomedin Binding Protein 2
13%
Cervical Cancer
13%
Doppler Ultrasound
13%
Doppler Flowmetry
13%
Acute Respiratory Distress Syndrome
13%
Malignant Ovarian Germ Cell Tumor
13%
Bevacizumab
13%
Dentigerous Cyst
13%
Stromelysin
13%
RNA Binding Protein
13%
Term Birth
13%
Treatment Response
13%
Brain Metastasis
13%
Tissue Inhibitor of Metalloproteinase 3
13%
Insulin-Like Growth Factor 1
13%
Aggressive Fibromatosis
13%
Malignant Transformation
13%
Radiation Therapy
13%
Clear Cell Carcinoma
13%
Biological Functions
13%
Paramethasone
13%
Multivariate Analysis
11%
Diseases
10%
Vascularity
9%
Capivasertib
9%
Univariate Analysis
9%
microRNA
8%
Recurrent Disease
8%
Cancer Staging
7%
Carcinoma Cell
7%
Receptor
7%
Keyphrases
COL11A1
26%
Epithelial Ovarian Carcinoma
15%
MiR-509-3p
13%
SC66
13%
Primary Peritoneal Cancer
13%
Plasmablastic Lymphoma
13%
Forkhead Box M1 (FOXM1)
13%
Biological Significance
13%
Growth Factors
13%
Biological Function
13%
Paravaginal
13%
Ovarian Carcinoma Cells
13%
Papillary Serous Carcinoma
13%
MiR-335
13%
Severe Acute Respiratory Distress Syndrome
13%
Acute Respiratory Distress Syndrome
13%
PDK1
13%
Influenza A
13%
Malignant Ovarian Germ Cell Tumor (MOGCT)
13%
Cell Fate Regulation
13%
Chemotherapeutic Regimens
13%
Practice Education
13%
Oncology
13%
Lin28
13%
Undergraduate nursing Students
13%
Early-stage Cervical Cancer
13%
Ovarian Cancer Cells
13%
AZD5363
13%
IGF System
13%
TIMP3
13%
Insulin-like Growth Factor Binding Protein (IGFBP)
13%
Small Cell Neuroendocrine Carcinoma of the Cervix
13%
Term Birth
13%
Fertility Sparing
13%
Insulin-like
13%
Desmoid-type Fibromatosis
13%
Chemoresistance
13%
Mesh Exposure
13%
Transvaginal Mesh Repair
13%
Surgical Predictors
13%
Ovarian Mature Cystic Teratoma
13%
Dose-escalation Study
13%
Pegylated Liposomal Doxorubicin
13%
First Relapse
13%
Peritoneal Cancer
13%
Tubal Cancer
13%
Solanum Incanum
13%
Twist1
13%
Insulin-like Growth Factor 1 Receptor (IGF1R)
8%
Omentectomy
6%
